Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H22N3O3P |
Molecular Weight | 275.2844 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)NP(=O)(N1CC1(C)C)N2CC2(C)C
InChI
InChIKey=QTFKTBRIGWJQQL-UHFFFAOYSA-N
InChI=1S/C11H22N3O3P/c1-6-17-9(15)12-18(16,13-7-10(13,2)3)14-8-11(14,4)5/h6-8H2,1-5H3,(H,12,15,16)
Meturedepa (also known as AB-132), an alkylating agent that was developed as an antineoplastic drug. Meturedepa was studied to treat lymphomas and leukemias. The drug also participated in the Eastern clinical drug evaluation program for 233 patients with advanced cancer. Information about the current use of this compound is not available.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Clinical experience with a new alkylating agent AB-132, in the treatment of lymphomas and leukemias. | 1962 May |
|
Prolonged apnea following succinylcholine in cancer patients receiving AB-132. | 1963 May-Jun |
|
COMBINED USE OF AB-132 (METUREDEPA, TURLOC) AND X-IRRADIATION IN THE MANAGEMENT OF ADVANCED BRONCHOGENIC CARCINOMA. | 1964 Jul |
|
Effects of meturedepa (NSC-51325) in 233 patients with advanced cancer. Eastern Clinical Drug Evaluation Program. | 1968 Oct |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C292
Created by
admin on Sat Dec 16 18:03:16 UTC 2023 , Edited by admin on Sat Dec 16 18:03:16 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
15456
Created by
admin on Sat Dec 16 18:03:16 UTC 2023 , Edited by admin on Sat Dec 16 18:03:16 UTC 2023
|
PRIMARY | |||
|
1423
Created by
admin on Sat Dec 16 18:03:16 UTC 2023 , Edited by admin on Sat Dec 16 18:03:16 UTC 2023
|
PRIMARY | |||
|
1661-29-6
Created by
admin on Sat Dec 16 18:03:16 UTC 2023 , Edited by admin on Sat Dec 16 18:03:16 UTC 2023
|
PRIMARY | |||
|
C1760
Created by
admin on Sat Dec 16 18:03:16 UTC 2023 , Edited by admin on Sat Dec 16 18:03:16 UTC 2023
|
PRIMARY | |||
|
m351
Created by
admin on Sat Dec 16 18:03:16 UTC 2023 , Edited by admin on Sat Dec 16 18:03:16 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000081156
Created by
admin on Sat Dec 16 18:03:16 UTC 2023 , Edited by admin on Sat Dec 16 18:03:16 UTC 2023
|
PRIMARY | |||
|
SUB08923MIG
Created by
admin on Sat Dec 16 18:03:16 UTC 2023 , Edited by admin on Sat Dec 16 18:03:16 UTC 2023
|
PRIMARY | |||
|
CHEMBL280685
Created by
admin on Sat Dec 16 18:03:16 UTC 2023 , Edited by admin on Sat Dec 16 18:03:16 UTC 2023
|
PRIMARY | |||
|
3784
Created by
admin on Sat Dec 16 18:03:16 UTC 2023 , Edited by admin on Sat Dec 16 18:03:16 UTC 2023
|
PRIMARY | |||
|
DTXSID60862727
Created by
admin on Sat Dec 16 18:03:16 UTC 2023 , Edited by admin on Sat Dec 16 18:03:16 UTC 2023
|
PRIMARY | |||
|
51325
Created by
admin on Sat Dec 16 18:03:16 UTC 2023 , Edited by admin on Sat Dec 16 18:03:16 UTC 2023
|
PRIMARY | |||
|
C024217
Created by
admin on Sat Dec 16 18:03:16 UTC 2023 , Edited by admin on Sat Dec 16 18:03:16 UTC 2023
|
PRIMARY | |||
|
43255365IF
Created by
admin on Sat Dec 16 18:03:16 UTC 2023 , Edited by admin on Sat Dec 16 18:03:16 UTC 2023
|
PRIMARY |
ACTIVE MOIETY